https://www.selleckchem.com/pr....oducts/ag-221-enasid
BackgroundCOVID-19 sequelae among veterans need evaluation. Design Propensity-score-matched retrospective cohort study. Participants A total 778,738 veterans, who were tested for COVID-19 at VA facilities between 20 February 2020-27 March 2021. Main Outcomes Development of new physical and mental health conditions (incidence) during the follow-up period of 7 days to 3 months after the diagnosis of COVID-19. Results Out of 778,738 veterans, 149,205 (19.2%) were inpatients and 629,533 (80.8%) were outpatients. 123,757 (15.9%) di
Like
Comment
Share
